Table 2 Proportion of malignancy as a function of Bethesda score for p-USFNA and r-USFNA
From: The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules
Diagnostic study | Bethesda score | Number of cases (%) | Malignant final pathology, n (%) |
|---|---|---|---|
p-USFNA | B3 | 81 (84.4) | 47 (58.0) |
B4 | 15 (15.6) | 10 (66.7) | |
r-USFNA | B3 | 55 (73.3) | 30 (54.6) |
B4 | 18 (26.7) | 10 (55.7) |